Robeco Institutional Asset Management B.V. Vertex Pharmaceuticals Inc Transaction History

Robeco Institutional Asset Management B.V.

$66.7 Billion
Q3 2025

A detailed history of Robeco Institutional Asset Management B.V. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 379,371 shares of VRTX stock, worth $165 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

379,371

Previous 329,391 15.17%

Holding current value

$165 Million

Previous $147 Million 1.32%

% of portfolio

0.22%

Previous 0.24%

45 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 22, 2025	BUY	$366.54 - $479.53 $18.3 Million - $24 Million	49,980 Added 15.17%	379,371 $149 Million
Q2 2025 Jul 18, 2025	BUY	$421.16 - $509.5 $77.2 Million - $93.4 Million	183,391 Added 125.61%	329,391 $147 Million
Q1 2025 Apr 23, 2025	SELL	$402.49 - $513.76 $56.7 Million - $72.3 Million	-140,756 Reduced 49.09%	146,000 $70.8 Million
Q4 2024 Jan 22, 2025	SELL	$396.64 - $516.74 $3.89 Million - $5.07 Million	-9,812 Reduced 3.31%	286,756 $115 Million
Q3 2024 Oct 29, 2024	SELL	$460.0 - $505.78 $33.9 Million - $37.2 Million	-73,643 Reduced 19.89%	296,568 $138 Million

Q2 2024 Jul 22, 2024	SELL	$392.81 - $485.53 $36.8 Million - $45.5 Million	-93,658 Reduced 20.19%	370,211 $174 Million
Q1 2024 Apr 24, 2024	BUY	$407.69 - $446.08 $2.46 Million - $2.7 Million	6,045 Added 1.32%	463,869 $194 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $72.9 Million - $87.3 Million	212,636 Added 86.72%	457,824 $186 Million
Q4 2023 Feb 08, 2024	SELL	$343.0 - $410.68 $64.4 Million - $77.1 Million	-187,749 Reduced 43.37%	245,188 $458 Million
Q3 2023 Oct 23, 2023	BUY	$338.18 - $362.46 $8.97 Million - $9.61 Million	26,523 Added 6.53%	432,937 $151 Million
Q2 2023 Jul 24, 2023	SELL	$314.42 - $351.91 $12.7 Million - $14.2 Million	-40,403 Reduced 9.04%	406,414 $143 Million
Q1 2023 May 03, 2023	SELL	$283.23 - $323.1 $7.12 Million - $8.12 Million	-25,140 Reduced 5.33%	446,817 $141 Million
Q4 2022 Feb 06, 2023	BUY	$285.76 - $321.48 $38 Million - $42.7 Million	132,927 Added 39.21%	471,957 $136 Million
Q3 2022 Dec 01, 2022	BUY	$273.83 - $305.53 $23.3 Million - $26 Million	85,003 Added 33.46%	339,030 $98.2 Million
Q3 2022 Oct 26, 2022	BUY	$273.83 - $305.53 $23.3 Million - $26 Million	85,003 Added 33.46%	339,030 $98.2 Million
Q2 2022 Dec 01, 2022	BUY	$234.96 - $292.55 $4.04 Million - $5.03 Million	17,195 Added 7.26%	254,027 $71.6 Million
Q2 2022 Jul 27, 2022	BUY	$234.96 - $292.55 $4.04 Million - $5.03 Million	17,195 Added 7.26%	254,027 $71.6 Million
Q1 2022 Dec 01, 2022	BUY	$221.42 - $260.97 $8.53 Million - $10.1 Million	38,514 Added 19.42%	236,832 $61.8 Million
Q1 2022 Apr 26, 2022	BUY	$221.42 - $260.97 $8.53 Million - $10.1 Million	38,514 Added 19.42%	236,832 $61.8 Million
Q4 2021 Dec 01, 2022	SELL	$177.01 - $223.45 $820,795 - $1.04 Million	-4,637 Reduced 2.28%	198,318 $43.6 Million
Q4 2021 Jan 31, 2022	SELL	$177.01 - $223.45 $820,795 - $1.04 Million	-4,637 Reduced 2.28%	198,318 $43.6 Million
Q3 2021 Dec 01, 2022	SELL	$181.39 - $202.99 $23,943 - $26,794	-132 Reduced 0.06%	202,955 $36.8 Million
Q3 2021 Oct 20, 2021	SELL	$181.39 - $202.99 $23,943 - $26,794	-132 Reduced 0.06%	202,955 $36.8 Million
Q2 2021 Dec 01, 2022	BUY	$187.49 - $221.1 $4.99 Million - $5.88 Million	26,595 Added 15.07%	203,087 $41 Million
Q2 2021 Jul 28, 2021	BUY	$187.49 - $221.1 $4.99 Million - $5.88 Million	26,595 Added 15.07%	203,087 $41 Million
Q1 2021 Dec 01, 2022	SELL	$207.02 - $241.31 $33.6 Million - $39.2 Million	-162,538 Reduced 47.94%	176,492 $37.9 Million
Q1 2021 Apr 23, 2021	SELL	$207.02 - $241.31 $23.2 Million - $27 Million	-112,005 Reduced 38.82%	176,492 $37.9 Million
Q4 2020 Dec 01, 2022	SELL	$207.01 - $276.09 $10.5 Million - $14 Million	-50,533 Reduced 14.91%	288,497 $68.2 Million
Q4 2020 Jan 28, 2021	SELL	$207.01 - $276.09 $14 Million - $18.6 Million	-67,392 Reduced 18.94%	288,497 $68.2 Million
Q3 2020 Oct 29, 2020	BUY	$255.65 - $303.1 $12.2 Million - $14.4 Million	47,537 Added 15.42%	355,889 $96.8 Million
Q2 2020 Jul 20, 2020	BUY	$225.48 - $295.8 $51.5 Million - $67.6 Million	228,379 Added 285.57%	308,352 $89.5 Million
Q1 2020 Apr 30, 2020	BUY	$199.77 - $247.81 $9.45 Million - $11.7 Million	47,325 Added 144.96%	79,973 $19 Million
Q4 2019 Feb 06, 2020	BUY	$166.71 - $223.91 $656,503 - $881,757	3,938 Added 13.72%	32,648 $7.15 Million
Q3 2019 Oct 17, 2019	SELL	$166.23 - $187.09 $1.49 Million - $1.68 Million	-8,982 Reduced 23.83%	28,710 $4.86 Million
Q2 2019 Jul 19, 2019	SELL	$164.61 - $190.37 $542,225 - $627,078	-3,294 Reduced 8.04%	37,692 $6.91 Million
Q1 2019 May 02, 2019	BUY	$163.73 - $194.7 $2.58 Million - $3.07 Million	15,783 Added 62.62%	40,986 $7.54 Million
Q4 2018 Feb 08, 2019	SELL	$151.91 - $192.21 $1.82 Million - $2.31 Million	-12,012 Reduced 32.28%	25,203 $4.18 Million
Q3 2018 Oct 31, 2018	BUY	$167.73 - $192.74 $36,565 - $42,017	218 Added 0.59%	37,215 $7.17 Million
Q3 2018 Oct 25, 2018	BUY	$167.73 - $192.74 $405,571 - $466,045	2,418 Added 6.99%	36,997 $7.13 Million
Q2 2018 Aug 03, 2018	SELL	$145.72 - $169.96 $298,580 - $348,248	-2,049 Reduced 5.59%	34,579 $5.88 Million
Q1 2018 May 07, 2018	BUY	$151.6 - $177.13 $1.51 Million - $1.76 Million	9,940 Added 37.25%	36,628 $5.97 Million
Q4 2017 Jan 25, 2018	BUY	$137.28 - $155.55 $1.51 Million - $1.71 Million	11,016 Added 70.29%	26,688 $4 Million
Q3 2017 Oct 17, 2017	BUY	$148.13 - $162.24 $5,777 - $6,327	39 Added 0.25%	15,672 $2.38 Million
Q2 2017 Aug 08, 2017	BUY	N/A	14,672 Added 1526.74%	15,633 $2.01 Million
Q1 2017 Jan 19, 2021	BUY	N/A	961	961 $105,000

Others Institutions Holding VRTX

# of Institutions

1,786

Shares Held

231M

Call Options Held

1.83M

Put Options Held

1.21M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $111B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Account

Robeco Institutional Asset Management B.V. Vertex Pharmaceuticals Inc Transaction History